Cardiol Therapeutics, Inc. – CardiolRx™ Phase II & III Outcomes Study
David Elsley, MBA, President and CEO of Cardiol Therapeutics, Inc., a clinical stage biotech, discusses the Company's research and clinical development ...
5264 articles
David Elsley, MBA, President and CEO of Cardiol Therapeutics, Inc., a clinical stage biotech, discusses the Company's research and clinical development ...
Sheri Mullen, Senior Vice President, Specialty Business Unit, US Pharma at GSK discusses BENLYSTA (belimumab), the first and only biologic approve...
Edio Zampaglione, Head of Global Medical Affairs and Outcomes Research at Organon and an OBGYN, discusses unintended pregnancies, the importance of star...
Jacob Teitelbaum, MD, discusses the recently released (June 2021) 4th edition of his book "From Fatigued to Fantastic: A Clinically Proven Program to Re...
Jim Joyce, co-founder, chairman, and CEO of Sigyn Therapeutics discusses the development of Sigyn Therapy, the company's blood purification technology t...
Sara Thomas, PhD, RD, registered dietician and research scientist at Abbott, discusses a new study from Abbott and The Ohio State University that was pu...
Rami Levin, President and CEO of Saniona discusses Tesomet, the first and only investigational treatment for Hypothalamic Obesity (HO) to receive orphan...
Bruce Bender, PhD, lead researcher and co-director of the Center for Health Promotion at National Jewish Health discusses recent research published in "...
Daniel Shapiro, author of "The Thin Ledge: A Husband's Memoir of Love, Trauma, and Unexpected Circumstances" shares the reality of the fifteen years he ...
Adam Sachs, co-founder and CEO of Vicarious Surgical, a company backed by Bill Gates and Vinod Khosla, discusses the company's Fantastic Voyage inspired...